tetano
Editor, Senior Moderator
Transl Gastroenterol Hepatol
. 2021 Oct 25;6:65.
doi: 10.21037/tgh-20-234. eCollection 2021.
Acute pancreatitis in a patient with COVID-19: a case report
Chiranjeevi Gadiparthi[SUP] 1 [/SUP], Sonmoon Mohapatra[SUP] 1 [/SUP], Sowjanya Kanna[SUP] 2 [/SUP], Vinit Vykuntam[SUP] 3 [/SUP], William Chen[SUP] 1 [/SUP]
Affiliations
Abstract
The global pandemic of coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is predominantly a respiratory illness, but gastrointestinal (GI) manifestations of variable severity have been reported. In patients with COVID-19 pneumonia, observational studies have demonstrated the elevation of pancreatic enzymes as surrogate markers for pancreatic injury without evidence of acute pancreatitis (AP). We report a case of AP in a patient with COVID-19 with SARS-CoV-2 as possible etiological agent with imaging evidence of pancreatitis. We hypothesize a causal relationship of SARS-CoV-2 in this patient with an otherwise unexplained presentation of AP after excluding the common causes. We postulate that AP in COVID-19 could be related to the abundant expression of angiotensin converting enzyme 2 (ACE 2) receptors in the pancreas which serve as viral entry binding receptors for SARS-CoV-2 or due to direct viral involvement of the pancreas. Although there seems to be an association between diabetes and AP, the available data regarding the etiological role of diabetes in causing AP is very limited. We also propose that imaging studies such as computerized tomography (CT) scan of the abdomen should be considered in the diagnosis of AP in patients with COVID-19 infection to exclude the false positive amylase and lipase.
Keywords: Acute pancreatitis (AP); case report; coronavirus disease-2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); structural damage.
. 2021 Oct 25;6:65.
doi: 10.21037/tgh-20-234. eCollection 2021.
Acute pancreatitis in a patient with COVID-19: a case report
Chiranjeevi Gadiparthi[SUP] 1 [/SUP], Sonmoon Mohapatra[SUP] 1 [/SUP], Sowjanya Kanna[SUP] 2 [/SUP], Vinit Vykuntam[SUP] 3 [/SUP], William Chen[SUP] 1 [/SUP]
Affiliations
- PMID: 34805587
- PMCID: PMC8573359
- DOI: 10.21037/tgh-20-234
Abstract
The global pandemic of coronavirus disease-2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is predominantly a respiratory illness, but gastrointestinal (GI) manifestations of variable severity have been reported. In patients with COVID-19 pneumonia, observational studies have demonstrated the elevation of pancreatic enzymes as surrogate markers for pancreatic injury without evidence of acute pancreatitis (AP). We report a case of AP in a patient with COVID-19 with SARS-CoV-2 as possible etiological agent with imaging evidence of pancreatitis. We hypothesize a causal relationship of SARS-CoV-2 in this patient with an otherwise unexplained presentation of AP after excluding the common causes. We postulate that AP in COVID-19 could be related to the abundant expression of angiotensin converting enzyme 2 (ACE 2) receptors in the pancreas which serve as viral entry binding receptors for SARS-CoV-2 or due to direct viral involvement of the pancreas. Although there seems to be an association between diabetes and AP, the available data regarding the etiological role of diabetes in causing AP is very limited. We also propose that imaging studies such as computerized tomography (CT) scan of the abdomen should be considered in the diagnosis of AP in patients with COVID-19 infection to exclude the false positive amylase and lipase.
Keywords: Acute pancreatitis (AP); case report; coronavirus disease-2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); structural damage.